Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands

Molecular Therapy

Volumn 15, Issue 12, 2007, Pages 2101-2106

  Cotrim, Ana P ^a   Sowers, Anastasia ^b   Mitchell, James B ^b   Baum, Bruce J ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BASIC FIBROBLAST GROWTH FACTOR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE THERAPY; HEAD AND NECK CANCER; MICROVASCULATURE; MOUSE; NONHUMAN; PARTICLE SIZE; RADIATION FIELD; RADIATION INJURY; SALIVARY GLAND; SALIVATION; SALIVATION DISORDER; VIRAL GENE DELIVERY SYSTEM;

ESCHERICHIA COLI; MUS;

EID: 36349032232     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300296     Document Type: Article

References (37)

1. Greenlee, RT, Hill-Harmon, MB, Murray, T and Thun, M (2001). Cancer statistics, 2001. CA Cancer J Clin 51: 15-36.
2. American Cancer Association. Cancer Statistics (2006). Presentation http://www.cancer.org/docroot/PRO/content/ PRO_1_1_Cancer_Statistics_2006_Presentation.asp
3. Division of Cancer Control and Population Sciences, National Cancer Institute (2004). 5-year relative survival rates based on cancer patients diagnosed from 1995 to 2000 and followed through 2001. Source: Surveillance, Epidemiology, and End Results Program, 1975-2001.
4. Vissink, A, Burlage, FR, Spijkervet, FK, Jansma, J and Coppes, RP (2003). Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 213-225.
5. Vissink, A, Jansma, J, Spijkervet FK, Burlage, FR and Coppes, RP (2003). Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 199-212.
6. Nagler, RM and Baum, BJ (2003). Prophylactic treatment reduces the severity of xerostomia following radiation therapy for oral cavity cancer. Arch Otolaryngol Head Neck Surg 129: 247-250.
7. Nagler, RM (2002). The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis 8: 141-146.
8. Konings, AW, Coppes, RP and Vissink, A (2005). On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62: 1187-1194.
9. Shiboski, CH, Hodgson, TA, Ship, JA and Schiodt, M (2007). Management of salivary hypofunction during and after radiotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 (Suppl. 66): E1-e19.
10. Paris, F, Fuks, Z, Kang, A, Capodieci, P, Juan, G, Ehleiter, D et al. (2001). Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293: 293-297.
11. Houchen, CW, George, RJ, Sturmoski, MA and Cohn, SM (1999). FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276: 249-258.
12. Okunieff, P, Mester, M, Wang, j, Maddox, T, Gong, X, Tang, D et al. (1998). In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat Res 150: 204-211.
13. Santana, P, Pena, LA, Haimovitz-Friedman, A, Martin, S, Green, D, McLoughlin, M et al. (1996). Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86: 189-199.
14. Pena, LA, Fuks, Z and Kolesnick, RN (2000). Radiation-induced apoptosis of endothelial cells in the murine central nervous system: Protection by fibroblast growth factor and sphingomyelinase deficiency. Cancer Res 60: 321-327.
15. Vitolo, JM, Cotrim, AP, Sowers, AL, Russo, A, Wellner, RB, Pillemer, SR et al. (2004). The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 10: 1807-1812.
16. Wang, S, Baum, BJ, Yamano, S, Mankani, MH, Sun, D, Jonsson, M et al. (2000). Adenoviral-mediated gene transfer to mouse salivary glands. J Dent Res 79: 701-708.
17. Voutetakis, A, Bossis, I, Kok, MR, Zhang, W, Wang, J, Cotrim, AP et al. (2005). Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders. J Endocrinol 185: 363-372.
18. Turley, H, Scott, PA, Watts, VM, Bicknell, R, Harris, AI and Gatter, KC (1998). Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol 186: 313-318.
19. Maharaj, AS, Saint-Geniez M, Maldonado AE and D'Amore PA (2006). Vascular endothelial growth factor localization in the adult. Am J Pathol 168: 639-648.
20. Kagami, H, Hiramatsu, Y, Hishida, S, Okazaki, Y, Horie, K, Oda, Y et al. (2000). Salivary growth factors in health and disease. Adv Dent Res 14: 99-102.
21. Schuller, BW, Binns, PJ, Riley, KJ, Ma, L, Hawthorne, MF and Coderre, JA (2006). Selective irradiation of the vascular endothelium has no effect on the survival of murine intestinal crypt stem cells. Proc Natl Acad Sci USA 103: 3787-3792.
22. Kolesnick, R and Fuks, Z (2003). Radiation and ceramide-induced apoptosis. Oncogene 22: 5897-5906.
23. Michael, JM, Lavin, MF and Watters, DL (1997). Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res 57: 3600-3605.
24. Shi, YQ, Wuergler, FE, Blattmann, H and Crompton, NE (2001). Distinct apoptotic phenotypes induced by radiation and ceramide in both p53-wild-type and p53-mutated lymphoblastoid cells. Radiat Environ Biophys 40: 301-308.
25. Radford, IR (1999). Initiation of ionizing radiation-induced apoptosis: DNA damage-mediated or does ceramide have a role? Int J Radiat Biol 75: 521-528.
26. Fei, P and El-Deiry, WS (2003). P53 and radiation responses. Oncogene 22: 5774-5783.
27. Preston, RJ (2005). Radiation biology: Concepts for radiation protection. Health Phys 88: 545-556.
28. O'Connell, AC, Lillibridge, CD, Zheng, C, Baum, BJ, O'Connell, BC and Ambudkar, IS (1998). Gamma-irradiation-induced cell cycle arrest and cell death in a human submandibular gland cell line: Effect of E2F1 expression. J Cell Physiol 177: 264-273.
29. O'Connell, AC, Redman, RS, Evans, RL and Ambudkar, IS (1999). Radiation-induced progressive decrease in fluid secretion in rat submandibular glands is related to decreased acinar volume and not impaired calcium signaling. Radiat Res 151: 150-158.
30. He, X, Goldsmith, CM, Marmary, Y, Wellner, RB, Parlow, AF, Nieman, LK et al. (1998). Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands. Gene Ther 5: 537-541.
31. Chandler, LA, Sosnowski, BA, Greenlees, L, Aukerman, SL, Baird, A and Pierce, GF (1999). Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. Int J Cancer 81: 451-458.
32. Delporte, C, O'Connell, BC, He, X, Lancaster, HE, O'Connell, AC, Agre, P et al. (1997). Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 94: 3268-3273.
33. Mittereder, N, March, KL and Trapnell, BC (1996). Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 70: 7498-7509.
34. Brown, AM, Rusnock, EJ, Sciubba, JJ and Baum, BJ (1989). Establishment and characterization of an epithelial cell line from the rat submandibular gland. J Oral Pathol Med 18: 206-213.
35. Zheng, C, O'Connell, BC and Baum, BJ (2003). Inclusion of Moloney murine leukemia virus elements upstream of the transgene cassette in an E1-deleted adenovirus leads to an unusual genomic integration in epithelial cells. Virology 313: 460-472.
36. Yamano, S, Huang, LY, Ding, C, Chiorini, JA, Goldsmith, CM, Wellner, RB et al. (2002). Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther 13: 287-298.
37. Pusztaszeri, MP, Seelentag, W and Bosman, FT (2006). Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54: 385-395.